Xiaohong Zhao

Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Dynamic expression of IL-21 in effector CD8 T cells helps control chronic infections.

Dynamic expression of IL-21 in effector CD8 T cells helps control chronic infections.

Journal: Science immunology

Published: July 31, 2026

Ms4a7 expression in cDC1s determines cross-presentation and antitumor immunity.

Ms4a7 expression in cDC1s determines cross-presentation and antitumor immunity.

Journal: Science (New York, N.Y.)

Published: November 13, 2025

The effector differentiation of TCRαβ+CD8αα+ intraepithelial lymphocytes is reciprocally regulated by BCL6 and BLIMP1.

The effector differentiation of TCRαβ+CD8αα+ intraepithelial lymphocytes is reciprocally regulated by BCL6 and BLIMP1.

Journal: Cell reports

Published: June 17, 2025

The FoxO4/DKK3 axis represses IFN-γ expression by Th1 cells and limits antimicrobial immunity.

The FoxO4/DKK3 axis represses IFN-γ expression by Th1 cells and limits antimicrobial immunity.

Journal: The Journal of clinical investigation

Published: March 17, 2025

Zbtb32 promotes CD8+ T cell differentiation and function in cancer.

Zbtb32 promotes CD8+ T cell differentiation and function in cancer.

Journal: The Journal of experimental medicine

Published: January 01, 2025

Regulatory T cells converted from Th1 cells in tumors suppress cancer immunity via CD39.

Regulatory T cells converted from Th1 cells in tumors suppress cancer immunity via CD39.

Journal: The Journal of experimental medicine

Published: March 11, 2024

BCL6 is required for the thymic development of TCRαβ+CD8αα+ intraepithelial lymphocyte lineage.

BCL6 is required for the thymic development of TCRαβ+CD8αα+ intraepithelial lymphocyte lineage.

Journal: Science immunology

Published: February 09, 2024

TRIM28 is an essential regulator of three-dimensional chromatin state underpinning CD8+ T cell activation.

TRIM28 is an essential regulator of three-dimensional chromatin state underpinning CD8+ T cell activation.

Journal: Nature communications

Published: January 21, 2024

Contrasting cytotoxic and regulatory T cell responses underlying distinct clinical outcomes to anti-PD-1 plus lenvatinib therapy in cancer.

Contrasting cytotoxic and regulatory T cell responses underlying distinct clinical outcomes to anti-PD-1 plus lenvatinib therapy in cancer.

Journal: Cancer cell

Published: November 20, 2023

BCL6 promotes a stem-like CD8+ T cell program in cancer via antagonizing BLIMP1.

BCL6 promotes a stem-like CD8+ T cell program in cancer via antagonizing BLIMP1.

Journal: Science immunology

Published: October 20, 2023

Correction: Cell autonomous expression of BCL6 is required to maintain lineage identity of mouse CCR6+ ILC3s.

Correction: Cell autonomous expression of BCL6 is required to maintain lineage identity of mouse CCR6+ ILC3s.

Journal: The Journal of experimental medicine

Published: July 17, 2023

NR4A1 transcriptionally regulates the differentiation of stem-like CD8+ T cells in the tumor microenvironment.

NR4A1 transcriptionally regulates the differentiation of stem-like CD8+ T cells in the tumor microenvironment.

Journal: Cell reports

Published: December 04, 2022

Showing 1-12 of 30

Last Updated: 09/26/2026